Pin Oak Investment Advisors’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Hold
498
0.01% 349
2026
Q1
$13K Hold
498
0.01% 341
2025
Q4
$15K Hold
498
0.01% 340
2025
Q3
$15.3K Buy
498
+117
+31% +$2.85K 0.01% 332
2025
Q2
$7K Hold
381
0.01% 353
2025
Q1
$8K Hold
381
0.01% 336
2024
Q4
$9K Hold
381
0.01% 345
2024
Q3
$9K Hold
381
0.01% 349
2024
Q2
$10K Hold
381
0.01% 332
2024
Q1
$11K Hold
381
0.01% 319
2023
Q4
$12K Hold
381
0.01% 307
2023
Q3
$13K Buy
+381
New +$14.5K 0.01% 294

Other funds holding GMAB

Pin Oak Investment Advisors's GMAB Position: Q2 2026 in Review

Pin Oak Investment Advisors held its Genmab (GMAB) position steady in Q2 2026 at 498 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #349.

Pin Oak Investment Advisors first reported a position in GMAB in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.3K in Q3 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pin Oak Investment Advisors held 498 shares of Genmab worth $14K as of Q2 2026.
  • Pin Oak Investment Advisors left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.01% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #349 holding.
  • Pin Oak Investment Advisors first reported a position in Genmab in Q3 2023 and has held it in 12 quarters since.
  • Pin Oak Investment Advisors's Genmab position peaked at $15.3K in Q3 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.